Global and China Healthcare-associated Infectious Disease Diagnostics Market Size, Status and Forecast 2023-2027

Report ID: 1127749 | Published Date: Jan 2025 | No. of Page: 119 | Base Year: 2024 | Rating: 4.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Healthcare-associated Infectious Disease Diagnostics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Urinary Tract Infections
        1.2.3 Surgical Site Infections
        1.2.4 Hospital-acquired Pneumonia
        1.2.5 BloodStream Infections
        1.2.6 Gastrointestinal Infections
    1.3 Market by Application
        1.3.1 Global Healthcare-associated Infectious Disease Diagnostics Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 ASCs
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Healthcare-associated Infectious Disease Diagnostics Market Perspective (2016-2027)
    2.2 Healthcare-associated Infectious Disease Diagnostics Growth Trends by Regions
        2.2.1 Healthcare-associated Infectious Disease Diagnostics Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Healthcare-associated Infectious Disease Diagnostics Historic Market Share by Regions (2016-2021)
        2.2.3 Healthcare-associated Infectious Disease Diagnostics Forecasted Market Size by Regions (2022-2027)
    2.3 Healthcare-associated Infectious Disease Diagnostics Industry Dynamic
        2.3.1 Healthcare-associated Infectious Disease Diagnostics Market Trends
        2.3.2 Healthcare-associated Infectious Disease Diagnostics Market Drivers
        2.3.3 Healthcare-associated Infectious Disease Diagnostics Market Challenges
        2.3.4 Healthcare-associated Infectious Disease Diagnostics Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Healthcare-associated Infectious Disease Diagnostics Players by Revenue
        3.1.1 Global Top Healthcare-associated Infectious Disease Diagnostics Players by Revenue (2016-2021)
        3.1.2 Global Healthcare-associated Infectious Disease Diagnostics Revenue Market Share by Players (2016-2021)
    3.2 Global Healthcare-associated Infectious Disease Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Healthcare-associated Infectious Disease Diagnostics Revenue
    3.4 Global Healthcare-associated Infectious Disease Diagnostics Market Concentration Ratio
        3.4.1 Global Healthcare-associated Infectious Disease Diagnostics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Healthcare-associated Infectious Disease Diagnostics Revenue in 2020
    3.5 Healthcare-associated Infectious Disease Diagnostics Key Players Head office and Area Served
    3.6 Key Players Healthcare-associated Infectious Disease Diagnostics Product Solution and Service
    3.7 Date of Enter into Healthcare-associated Infectious Disease Diagnostics Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Healthcare-associated Infectious Disease Diagnostics Breakdown Data by Type
    4.1 Global Healthcare-associated Infectious Disease Diagnostics Historic Market Size by Type (2016-2021)
    4.2 Global Healthcare-associated Infectious Disease Diagnostics Forecasted Market Size by Type (2022-2027)

5 Healthcare-associated Infectious Disease Diagnostics Breakdown Data by Application
    5.1 Global Healthcare-associated Infectious Disease Diagnostics Historic Market Size by Application (2016-2021)
    5.2 Global Healthcare-associated Infectious Disease Diagnostics Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Healthcare-associated Infectious Disease Diagnostics Market Size (2016-2027)
    6.2 North America Healthcare-associated Infectious Disease Diagnostics Market Size by Type
        6.2.1 North America Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2016-2021)
        6.2.2 North America Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2022-2027)
        6.2.3 North America Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2016-2027)
    6.3 North America Healthcare-associated Infectious Disease Diagnostics Market Size by Application
        6.3.1 North America Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2016-2021)
        6.3.2 North America Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2022-2027)
        6.3.3 North America Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2016-2027)
    6.4 North America Healthcare-associated Infectious Disease Diagnostics Market Size by Country
        6.4.1 North America Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2016-2021)
        6.4.2 North America Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Healthcare-associated Infectious Disease Diagnostics Market Size (2016-2027)
    7.2 Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Type
        7.2.1 Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2016-2021)
        7.2.2 Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2022-2027)
        7.2.3 Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2016-2027)
    7.3 Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Application
        7.3.1 Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2016-2021)
        7.3.2 Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2022-2027)
        7.3.3 Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2016-2027)
    7.4 Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Country
        7.4.1 Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2016-2021)
        7.4.2 Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size (2016-2027)
    8.2 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Type
        8.2.1 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2016-2027)
    8.3 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Application
        8.3.1 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2016-2027)
    8.4 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Region
        8.4.1 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size (2016-2027)
    9.2 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Type
        9.2.1 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2016-2021)
        9.2.2 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2022-2027)
        9.2.3 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2016-2027)
    9.3 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Application
        9.3.1 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2016-2021)
        9.3.2 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2022-2027)
        9.3.3 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2016-2027)
    9.4 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Country
        9.4.1 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2016-2021)
        9.4.2 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size (2016-2027)
    10.2 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Type
        10.2.1 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2016-2027)
    10.3 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Application
        10.3.1 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2016-2027)
    10.4 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Country
        10.4.1 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Abbott
        11.1.1 Abbott Company Details
        11.1.2 Abbott Business Overview
        11.1.3 Abbott Healthcare-associated Infectious Disease Diagnostics Introduction
        11.1.4 Abbott Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021)
        11.1.5 Abbott Recent Development
    11.2 Accelerate Diagnostics
        11.2.1 Accelerate Diagnostics Company Details
        11.2.2 Accelerate Diagnostics Business Overview
        11.2.3 Accelerate Diagnostics Healthcare-associated Infectious Disease Diagnostics Introduction
        11.2.4 Accelerate Diagnostics Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021)
        11.2.5 Accelerate Diagnostics Recent Development
    11.3 BD
        11.3.1 BD Company Details
        11.3.2 BD Business Overview
        11.3.3 BD Healthcare-associated Infectious Disease Diagnostics Introduction
        11.3.4 BD Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021)
        11.3.5 BD Recent Development
    11.4 bioMrieux
        11.4.1 bioMrieux Company Details
        11.4.2 bioMrieux Business Overview
        11.4.3 bioMrieux Healthcare-associated Infectious Disease Diagnostics Introduction
        11.4.4 bioMrieux Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021)
        11.4.5 bioMrieux Recent Development
    11.5 Bio-Rad
        11.5.1 Bio-Rad Company Details
        11.5.2 Bio-Rad Business Overview
        11.5.3 Bio-Rad Healthcare-associated Infectious Disease Diagnostics Introduction
        11.5.4 Bio-Rad Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021)
        11.5.5 Bio-Rad Recent Development
    11.6 DiaSorin Molecular
        11.6.1 DiaSorin Molecular Company Details
        11.6.2 DiaSorin Molecular Business Overview
        11.6.3 DiaSorin Molecular Healthcare-associated Infectious Disease Diagnostics Introduction
        11.6.4 DiaSorin Molecular Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021)
        11.6.5 DiaSorin Molecular Recent Development
    11.7 F. Hoffmann-La Roche
        11.7.1 F. Hoffmann-La Roche Company Details
        11.7.2 F. Hoffmann-La Roche Business Overview
        11.7.3 F. Hoffmann-La Roche Healthcare-associated Infectious Disease Diagnostics Introduction
        11.7.4 F. Hoffmann-La Roche Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021)
        11.7.5 F. Hoffmann-La Roche Recent Development
    11.8 Luminex
        11.8.1 Luminex Company Details
        11.8.2 Luminex Business Overview
        11.8.3 Luminex Healthcare-associated Infectious Disease Diagnostics Introduction
        11.8.4 Luminex Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021)
        11.8.5 Luminex Recent Development
    11.9 Meridian Bioscience
        11.9.1 Meridian Bioscience Company Details
        11.9.2 Meridian Bioscience Business Overview
        11.9.3 Meridian Bioscience Healthcare-associated Infectious Disease Diagnostics Introduction
        11.9.4 Meridian Bioscience Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021)
        11.9.5 Meridian Bioscience Recent Development
    11.10 OpGen
        11.10.1 OpGen Company Details
        11.10.2 OpGen Business Overview
        11.10.3 OpGen Healthcare-associated Infectious Disease Diagnostics Introduction
        11.10.4 OpGen Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021)
        11.10.5 OpGen Recent Development
    11.11 QIAGEN
        11.11.1 QIAGEN Company Details
        11.11.2 QIAGEN Business Overview
        11.11.3 QIAGEN Healthcare-associated Infectious Disease Diagnostics Introduction
        11.11.4 QIAGEN Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021)
        11.11.5 QIAGEN Recent Development
    11.12 Quidel
        11.12.1 Quidel Company Details
        11.12.2 Quidel Business Overview
        11.12.3 Quidel Healthcare-associated Infectious Disease Diagnostics Introduction
        11.12.4 Quidel Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021)
        11.12.5 Quidel Recent Development
    11.13 Thermo Fisher Scientific
        11.13.1 Thermo Fisher Scientific Company Details
        11.13.2 Thermo Fisher Scientific Business Overview
        11.13.3 Thermo Fisher Scientific Healthcare-associated Infectious Disease Diagnostics Introduction
        11.13.4 Thermo Fisher Scientific Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021)
        11.13.5 Thermo Fisher Scientific Recent Development
    11.14 Trinity Biotech
        11.14.1 Trinity Biotech Company Details
        11.14.2 Trinity Biotech Business Overview
        11.14.3 Trinity Biotech Healthcare-associated Infectious Disease Diagnostics Introduction
        11.14.4 Trinity Biotech Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021)
        11.14.5 Trinity Biotech Recent Development
    11.15 Danaher
        11.15.1 Danaher Company Details
        11.15.2 Danaher Business Overview
        11.15.3 Danaher Healthcare-associated Infectious Disease Diagnostics Introduction
        11.15.4 Danaher Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021)
        11.15.5 Danaher Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Healthcare-associated Infectious Disease Diagnostics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Urinary Tract Infections
    Table 3. Key Players of Surgical Site Infections
    Table 4. Key Players of Hospital-acquired Pneumonia
    Table 5. Key Players of BloodStream Infections
    Table 6. Key Players of Gastrointestinal Infections
    Table 7. Global Healthcare-associated Infectious Disease Diagnostics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 8. Global Healthcare-associated Infectious Disease Diagnostics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 9. Global Healthcare-associated Infectious Disease Diagnostics Market Size by Regions (2016-2021) & (US$ Million)
    Table 10. Global Healthcare-associated Infectious Disease Diagnostics Market Share by Regions (2016-2021)
    Table 11. Global Healthcare-associated Infectious Disease Diagnostics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 12. Global Healthcare-associated Infectious Disease Diagnostics Market Share by Regions (2022-2027)
    Table 13. Healthcare-associated Infectious Disease Diagnostics Market Trends
    Table 14. Healthcare-associated Infectious Disease Diagnostics Market Drivers
    Table 15. Healthcare-associated Infectious Disease Diagnostics Market Challenges
    Table 16. Healthcare-associated Infectious Disease Diagnostics Market Restraints
    Table 17. Global Healthcare-associated Infectious Disease Diagnostics Revenue by Players (2016-2021) & (US$ Million)
    Table 18. Global Healthcare-associated Infectious Disease Diagnostics Market Share by Players (2016-2021)
    Table 19. Global Top Healthcare-associated Infectious Disease Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Healthcare-associated Infectious Disease Diagnostics as of 2020)
    Table 20. Ranking of Global Top Healthcare-associated Infectious Disease Diagnostics Companies by Revenue (US$ Million) in 2020
    Table 21. Global 5 Largest Players Market Share by Healthcare-associated Infectious Disease Diagnostics Revenue (CR5 and HHI) & (2016-2021)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Healthcare-associated Infectious Disease Diagnostics Product Solution and Service
    Table 24. Date of Enter into Healthcare-associated Infectious Disease Diagnostics Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2016-2021) (US$ Million)
    Table 27. Global Healthcare-associated Infectious Disease Diagnostics Revenue Market Share by Type (2016-2021)
    Table 28. Global Healthcare-associated Infectious Disease Diagnostics Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 29. Global Healthcare-associated Infectious Disease Diagnostics Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 30. Global Healthcare-associated Infectious Disease Diagnostics Market Size Share by Application (2016-2021) & (US$ Million)
    Table 31. Global Healthcare-associated Infectious Disease Diagnostics Revenue Market Share by Application (2016-2021)
    Table 32. Global Healthcare-associated Infectious Disease Diagnostics Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 33. Global Healthcare-associated Infectious Disease Diagnostics Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 34. North America Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2016-2021) (US$ Million)
    Table 35. North America Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2022-2027) & (US$ Million)
    Table 36. North America Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2016-2021) (US$ Million)
    Table 37. North America Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2022-2027) & (US$ Million)
    Table 38. North America Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2016-2021) & (US$ Million) 
    Table 39. North America Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2022-2027) & (US$ Million) 
    Table 40. Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2016-2021) (US$ Million)
    Table 41. Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2022-2027) & (US$ Million)
    Table 42. Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2016-2021) (US$ Million)
    Table 43. Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2022-2027) & (US$ Million)
    Table 44. Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2016-2021) & (US$ Million) 
    Table 45. Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2022-2027) & (US$ Million) 
    Table 46. Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2016-2021) (US$ Million)
    Table 47. Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2022-2027) & (US$ Million)
    Table 48. Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2016-2021) (US$ Million)
    Table 49. Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2022-2027) & (US$ Million)
    Table 50. Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Region (2016-2021) & (US$ Million) 
    Table 51. Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Region (2022-2027) & (US$ Million) 
    Table 52. Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2016-2021) (US$ Million)
    Table 53. Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2022-2027) & (US$ Million)
    Table 54. Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2016-2021) (US$ Million)
    Table 55. Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2022-2027) & (US$ Million)
    Table 56. Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2016-2021) & (US$ Million) 
    Table 57. Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2022-2027) & (US$ Million) 
    Table 58. Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2016-2021) (US$ Million)
    Table 59. Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2022-2027) & (US$ Million)
    Table 60. Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2016-2021) (US$ Million)
    Table 61. Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2022-2027) & (US$ Million)
    Table 62. Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2016-2021) & (US$ Million) 
    Table 63. Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2022-2027) & (US$ Million) 
    Table 64. Abbott Company Details
    Table 65. Abbott Business Overview
    Table 66. Abbott Healthcare-associated Infectious Disease Diagnostics Product
    Table 67. Abbott Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021) & (US$ Million)
    Table 68. Abbott Recent Development
    Table 69. Accelerate Diagnostics Company Details
    Table 70. Accelerate Diagnostics Business Overview
    Table 71. Accelerate Diagnostics Healthcare-associated Infectious Disease Diagnostics Product
    Table 72. Accelerate Diagnostics Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021) & (US$ Million)
    Table 73. Accelerate Diagnostics Recent Development
    Table 74. BD Company Details
    Table 75. BD Business Overview
    Table 76. BD Healthcare-associated Infectious Disease Diagnostics Product
    Table 77. BD Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021) & (US$ Million)
    Table 78. BD Recent Development
    Table 79. bioMrieux Company Details
    Table 80. bioMrieux Business Overview
    Table 81. bioMrieux Healthcare-associated Infectious Disease Diagnostics Product
    Table 82. bioMrieux Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021) & (US$ Million)
    Table 83. bioMrieux Recent Development
    Table 84. Bio-Rad Company Details
    Table 85. Bio-Rad Business Overview
    Table 86. Bio-Rad Healthcare-associated Infectious Disease Diagnostics Product
    Table 87. Bio-Rad Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021) & (US$ Million)
    Table 88. Bio-Rad Recent Development
    Table 89. DiaSorin Molecular Company Details
    Table 90. DiaSorin Molecular Business Overview
    Table 91. DiaSorin Molecular Healthcare-associated Infectious Disease Diagnostics Product
    Table 92. DiaSorin Molecular Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021) & (US$ Million)
    Table 93. DiaSorin Molecular Recent Development
    Table 94. F. Hoffmann-La Roche Company Details
    Table 95. F. Hoffmann-La Roche Business Overview
    Table 96. F. Hoffmann-La Roche Healthcare-associated Infectious Disease Diagnostics Product
    Table 97. F. Hoffmann-La Roche Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021) & (US$ Million)
    Table 98. F. Hoffmann-La Roche Recent Development
    Table 99. Luminex Company Details
    Table 100. Luminex Business Overview
    Table 101. Luminex Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021) & (US$ Million)
    Table 102. Luminex Recent Development
    Table 103. Meridian Bioscience Company Details
    Table 104. Meridian Bioscience Business Overview
    Table 105. Meridian Bioscience Healthcare-associated Infectious Disease Diagnostics Product
    Table 106. Meridian Bioscience Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021) & (US$ Million)
    Table 107. Meridian Bioscience Recent Development
    Table 108. OpGen Company Details
    Table 109. OpGen Business Overview
    Table 110. OpGen Healthcare-associated Infectious Disease Diagnostics Product
    Table 111. OpGen Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021) & (US$ Million)
    Table 112. OpGen Recent Development
    Table 113. QIAGEN Company Details
    Table 114. QIAGEN Business Overview
    Table 115. QIAGEN Healthcare-associated Infectious Disease Diagnostics Product
    Table 116. QIAGEN Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021) & (US$ Million)
    Table 117. QIAGEN Recent Development
    Table 118. Quidel Company Details
    Table 119. Quidel Business Overview
    Table 120. Quidel Healthcare-associated Infectious Disease Diagnostics Product
    Table 121. Quidel Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021) & (US$ Million)
    Table 122. Quidel Recent Development
    Table 123. Thermo Fisher Scientific Company Details
    Table 124. Thermo Fisher Scientific Business Overview
    Table 125. Thermo Fisher Scientific Healthcare-associated Infectious Disease Diagnostics Product
    Table 126. Thermo Fisher Scientific Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021) & (US$ Million)
    Table 127. Thermo Fisher Scientific Recent Development
    Table 128. Trinity Biotech Company Details
    Table 129. Trinity Biotech Business Overview
    Table 130. Trinity Biotech Healthcare-associated Infectious Disease Diagnostics Product
    Table 131. Trinity Biotech Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021) & (US$ Million)
    Table 132. Trinity Biotech Recent Development
    Table 133. Danaher Company Details
    Table 134. Danaher Business Overview
    Table 135. Danaher Healthcare-associated Infectious Disease Diagnostics Product
    Table 136. Danaher Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021) & (US$ Million)
    Table 137. Danaher Recent Development
    Table 138. Research Programs/Design for This Report
    Table 139. Key Data Information from Secondary Sources
    Table 140. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Healthcare-associated Infectious Disease Diagnostics Market Share by Type: 2020 VS 2027
    Figure 2. Urinary Tract Infections Features
    Figure 3. Surgical Site Infections Features
    Figure 4. Hospital-acquired Pneumonia Features
    Figure 5. BloodStream Infections Features
    Figure 6. Gastrointestinal Infections Features
    Figure 7. Global Healthcare-associated Infectious Disease Diagnostics Market Share by Application: 2020 VS 2027
    Figure 8. Hospitals Case Studies
    Figure 9. Clinics Case Studies
    Figure 10. ASCs Case Studies
    Figure 11. Healthcare-associated Infectious Disease Diagnostics Report Years Considered
    Figure 12. Global Healthcare-associated Infectious Disease Diagnostics Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 13. Global Healthcare-associated Infectious Disease Diagnostics Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 14. Global Healthcare-associated Infectious Disease Diagnostics Market Share by Regions: 2020 VS 2027
    Figure 15. Global Healthcare-associated Infectious Disease Diagnostics Market Share by Regions (2022-2027)
    Figure 16. Global Healthcare-associated Infectious Disease Diagnostics Market Share by Players in 2020
    Figure 17. Global Top Healthcare-associated Infectious Disease Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Healthcare-associated Infectious Disease Diagnostics as of 2020
    Figure 18. The Top 10 and 5 Players Market Share by Healthcare-associated Infectious Disease Diagnostics Revenue in 2020
    Figure 19. Global Healthcare-associated Infectious Disease Diagnostics Revenue Market Share by Type (2016-2021)
    Figure 20. Global Healthcare-associated Infectious Disease Diagnostics Revenue Market Share by Type (2022-2027)
    Figure 21. North America Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 22. North America Healthcare-associated Infectious Disease Diagnostics Market Share by Type (2016-2027)
    Figure 23. North America Healthcare-associated Infectious Disease Diagnostics Market Share by Application (2016-2027)
    Figure 24. North America Healthcare-associated Infectious Disease Diagnostics Market Share by Country (2016-2027)
    Figure 25. United States Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Canada Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 27. Europe Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 28. Europe Healthcare-associated Infectious Disease Diagnostics Market Share by Type (2016-2027)
    Figure 29. Europe Healthcare-associated Infectious Disease Diagnostics Market Share by Application (2016-2027)
    Figure 30. Europe Healthcare-associated Infectious Disease Diagnostics Market Share by Country (2016-2027)
    Figure 31. Germany Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. France Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. U.K. Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Italy Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Russia Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Nordic Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Share by Type (2016-2027)
    Figure 39. Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Share by Application (2016-2027)
    Figure 40. Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Share by Region (2016-2027)
    Figure 41. China Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. Japan Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. South Korea Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Southeast Asia Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. India Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Australia Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Latin America Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. Latin America Healthcare-associated Infectious Disease Diagnostics Market Share by Type (2016-2027)
    Figure 49. Latin America Healthcare-associated Infectious Disease Diagnostics Market Share by Application (2016-2027)
    Figure 50. Latin America Healthcare-associated Infectious Disease Diagnostics Market Share by Country (2016-2027)
    Figure 51. Mexico Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Brazil Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 53. Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 54. Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Share by Type (2016-2027)
    Figure 55. Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Share by Application (2016-2027)
    Figure 56. Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Share by Country (2016-2027)
    Figure 57. Turkey Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. Saudi Arabia Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 59. UAE Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 60. Abbott Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021)
    Figure 61. Accelerate Diagnostics Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021)
    Figure 62. BD Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021)
    Figure 63. bioMrieux Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021)
    Figure 64. Bio-Rad Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021)
    Figure 65. DiaSorin Molecular Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021)
    Figure 66. F. Hoffmann-La Roche Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021)
    Figure 67. Luminex Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021)
    Figure 68. Meridian Bioscience Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021)
    Figure 69. OpGen Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021)
    Figure 70. QIAGEN Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021)
    Figure 71. Quidel Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021)
    Figure 72. Thermo Fisher Scientific Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021)
    Figure 73. Trinity Biotech Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021)
    Figure 74. Danaher Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021)
    Figure 75. Bottom-up and Top-down Approaches for This Report
    Figure 76. Data Triangulation
    Figure 77. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Abbott
Accelerate Diagnostics
BD
bioMrieux
Bio-Rad
DiaSorin Molecular
F. Hoffmann-La Roche
Luminex
Meridian Bioscience
OpGen
QIAGEN
Quidel
Thermo Fisher Scientific
Trinity Biotech
Danaher
Frequently Asked Questions
Healthcare-associated Infectious Disease Diagnostics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Healthcare-associated Infectious Disease Diagnostics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Healthcare-associated Infectious Disease Diagnostics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports